Andrea S. Blevins Primeau, PhD, MBA

Andrea S. Blevins Primeau, PhD, MBA, is a freelance medical writer and editor based in central Pennsylvania. She enjoys writing about a variety of topics including oncology, cardiovascular disease, and autoimmune disorders. Previously, she conducted research investigating the role of pharmacogenetics on the efficacy of oncologic therapies.

All articles by Andrea S. Blevins Primeau, PhD, MBA

lung cancer

Asthma

Cannabinoid Receptor CB2 Is a Potential Prognostic Biomarker in NSCLC

By

Andrea S. Blevins Primeau, PhD, MBA

October 8, 2020

Overexpression of cannabinoid receptor CB2 may be a prognostic biomarker for NSCLC adenocarcinomas.

This fact sheet evaluates the data that suggest that aspirin can reduce the risk of liver and ovaria

Common Cardiovascular Drugs Associated With Reduced Lung Cancer Mortality

By

Andrea S. Blevins Primeau, PhD, MBA

October 6, 2020

Aspirin, metformin, and statins were independently associated with decreased lung cancer mortality, according to a population-based study.

Next post in Lung Cancer

doctor holding lung cancer xray

COVID-19 Pandemic Has Affected Lung Cancer Treatment Plans